{{Infobox Drug|
|IUPAC_name = ''3-(4-bromophenyl)-N,N-dimethyl-''<br>''3-pyridin-2-yl-propan-1-amine''
| image=Brompheniramine.png
| width=120
| CAS_number=86-22-6
| ATC_prefix=R06
| ATC_suffix=AB01
| ATC_supplemental=
| PubChem=6834
| DrugBank=APRD00832
| C=16 | H=19 | Br=1 | N=2
| molecular_weight = 319.24
| bioavailability= ?
| metabolism = 肝
| elimination_half-life= ?
| excretion = ?
| pregnancy_category = C<small>（美國）</small>
| legal_status = 非處方藥
| routes_of_administration= 口服
}}'''溴苯那敏'''(Brompheniramine)是一種用於過敏症狀的藥物，屬於第一代组胺H1受体拮抗剂（又稱抗組織胺），化学式C<sub>16</sub>H<sub>19</sub>BrN<sub>2</sub>。其鹽類'''馬來酸溴苯那敏'''(Brompheniramine maleate)常用於藥品中。溴苯那敏的用途及不良反應與同類藥物氯苯那敏相似。

==適應症及用量==
減輕過敏症狀，例如過敏性鼻炎（包括花粉症）、荨麻疹等。溴苯那敏可減輕流鼻涕及噴嚏。用於口服時，成人劑量通常是每4至6小時服4毫克。

==不良反應==
主要是容易令人產生睡意，其它比較常見的不良反應有頭痛、小便滯留、口乾、腸胃不適等。

{{Drugbox|
|IUPAC_name = ''3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-yl-propan-1-amine''
| image=Brompheniramine structure.svg
| width=160
| CAS_number=86-22-6
| ATC_prefix=R06
| ATC_suffix=AB01
| ATC_supplemental=
| PubChem=6834
| DrugBank=APRD00832
| C=16 | H=19 | Br=1 | N=2
| molecular_weight = 319.24
| bioavailability= ?
| metabolism = Hepatic
| elimination_half-life= ?
| excretion = Urine
| pregnancy_category = C (USA)
| legal_status = Unscheduled, OTC
| routes_of_administration= Oral
}}
'''Brompheniramine''' (also known as '''Bromfed''', '''Dimetapp''', '''Bromfenex''', and '''Dimetane''') is an over the counter and is indicated for the treatment of the symptoms of the common cold and allergic rhinitis, such as runny nose, itchy eyes, watery eyes, and sneezing. It is a first-generation antihistamine.

Brompheniramine has antidepressant properties, inhibiting reuptake of the neurotransmitter serotonin. Based on this knowledge, Arvid Carlsson
and his colleagues, working at the Swedish company Astra AB, were able to derive the first marketed selective serotonin reuptake inhibitor, zimelidine, from brompheniramine.<ref name="Barondes">{{cite book
| first= Samuel H.
| last= Barondes
| year= 2003
| month= 
| title= Better Than Prozac
| pages= 39-40
| location= New York | publisher=Oxford University Press
| id= ISBN 0-19-515130-5
}}</ref>

Like other agents of this type, brompheniramine also has analgesic-sparing (potentiating) effects on opioid analgesics, commonly reducing codeine, dihydrocodeine, and hydrocodone requirements by 10 to 35 per cent. 

==Pharmacology==
Brompheniramine works by acting as an antagonist of histamine H<sub>1</sub> receptors. It also functions as a moderately effective anticholinergic agent, and is likely an antimuscarinic agent similar to other common antihistamines such as diphenhydramine. 

Brompheniramine is metabolised via cytochrome P450 oxidase.